FTC delays enforcement of ‘click-to-cancel' for subscriptions by 60 days
May 10 (UPI) -- The Federal Trade Commission has delayed enforcing the Negative Option Rule, which is the "click-to-cancel" option requiring companies to make it as easy to cancel subscriptions and other programs.
On Friday, commission members by a 3-0 vote deferred required compliance by 60 days to July 14.
"Of course, if that enforcement experience exposes problems with the Rule, the Commission is open to amending the Rule to address any such problems," the commission said in a statement.
The rule that went into effect on Jan. 19 that includes physical and digital subscriptions as well marketing, including prenotification plans, continuity plans, automatic renewals and free trial conversion offers.
Consumers often found it was difficult to cancel them without a few clicks on a website.
The FTC introduced the Negative Option Rule in 1973 to regulate continuity plans, automatic renewals and free trial offers, regardless of whether they appeared online, on the phone or in person.
The amendments to the Negative Option Rule strengthen the rule. The amendments "require companies that sign consumers up for recurring charges to clearly and conspicuously disclose all material terms of the transaction and to obtain express informed consent to a negative-option feature. And they prohibit companies from making it any more difficult for consumers to cancel than it was to sign up."
Companies also must provide relevant information about cancellation before they collect customers' money.
Because of concerns "it would take a substantial amount of time to come into compliance," the agency originally deferred it until May 14, the commission said.
After "a fresh assessment of the burdens that forcing compliance by this date would impose," it was delayed another 60 days.
The amended rule was first proposed in 2023.
The Eighth Circuit is considering a challenge to the rule by industry groups. The court declined to stay the implementation dates in January. That circuit includes seven Plains states.
Copyright 2025 UPI News Corporation. All Rights Reserved.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 hours ago
- Yahoo
BRYAN SEELEY NAMED INAUGURAL CEO OF THE COLLEGE SPORTS COMMISSION
Long-time MLB executive brings wealth of legal, executive experience to new role WASHINGTON, June 6, 2025 /PRNewswire/ -- The College Sports Commission, the newly established independent body tasked with overseeing the transformative changes to college athletics following the landmark House settlement, is proud to announce the selection of Bryan Seeley as its first Chief Executive Officer. A deeply experienced legal and operational leader with a distinguished career in professional sports and public service, Seeley will lead the Commission as a new era of fairness, integrity, and opportunity begins in college athletics. Seeley will officially begin this role in the near future. Seeley brings with him a wealth of experience handling high-profile legal and compliance matters and building teams to perform complex work in the sports industry. Most recently, Seeley served as Executive Vice President, Legal & Operations at Major League Baseball (MLB) where he served on MLB Commissioner Rob Manfred's executive leadership team, oversaw investigations into a wide range of issues including circumvention of international compensation caps, and developed and enforced rules in evolving policy areas such as legalized sports betting. Prior to joining MLB in 2014, Seeley served for eight years as an Assistant U.S. Attorney in Washington, D.C. where he prosecuted a wide variety of criminal activity. His collaborative leadership style and proven ability to navigate sensitive matters make him uniquely suited to guide the College Sports Commission in implementing the settlement's terms, enforcing the new rules and fostering a sustainable future for college athletics. As the first CEO of the College Sports Commission, Seeley will build out the organization's investigative and enforcement teams and oversee all of its ongoing operations and stakeholder relationships. The College Sports Commission, under Seeley's leadership, will work to continuously educate student-athletes and schools about the new rules, how to comply with them and how to use the new technology systems (CAPS and NIL Go) that the Commission is putting in place. Seeley and his team will also be responsible for enforcement of the new rules around revenue sharing, student-athlete third-party name image and likeness (NIL) deals, and roster limits. The Commission will investigate potential rules violations, make factual determinations, issue penalties where appropriate, and participate in the neutral arbitration process set forth in the settlement as necessary. Reflecting on his appointment, Seeley said: "I am honored to serve as the first CEO of the College Sports Commission at this pivotal moment in the history of collegiate athletics. I look forward to implementing a system that prioritizes fairness, integrity, and opportunity, while preserving the values that make college sports unique. I am energized by the work ahead and excited to begin building out our team." Atlantic Coast Conference Commissioner Jim Phillips, Big Ten Conference Commissioner Tony Petitti, Big 12 Conference Commissioner Brett Yormark and Southeastern Conference Commissioner Greg Sankey released the following joint statement, expressing enthusiasm for Seeley's leadership: "Bryan brings unwavering integrity and a wealth of relevant experience to his new role leading the College Sports Commission and working to ensure a smooth implementation of this new system. We're grateful to have an individual with his credentials and expertise at the helm, and we look forward to his leadership as we transition into this new era of college sports." "Bryan is an exceptional choice to lead the College Sports Commission," said Major League Baseball Commissioner Rob Manfred. "During his time at MLB, Bryan demonstrated unparalleled integrity, a commitment to fairness, and the ability to navigate complex challenges with precision and care. I have no doubt he will bring the same level of excellence to the College Sports Commission. College sports will greatly benefit from Bryan's expertise and vision." Seely's appointment follows the announcement of the court approval of the House v. NCAA settlement agreement and the subsequent establishment of the College Sports Commission. For more information about the College Sports Commission, please visit MEDIA CONTACTcollegesportscommission@ ABOUT THE COLLEGE SPORTS COMMISSIONThe College Sports Commission is an independent body established to ensure compliance with rules around roster limits, revenue sharing and student-athlete third-party NIL deals in college sports. The College Sports Commission is committed to prioritizing fairness, integrity and opportunity for student-athletes and institutions alike. View original content: SOURCE College Sports Commission
Yahoo
20 hours ago
- Yahoo
NSCEB Announces Biotech Across America Roadshow, Makes First Stop in North Carolina
NSCEB is launching a 3-month tour of the booming U.S. biotechnology ecosystem RALEIGH, N.C., June 6, 2025 /PRNewswire/ -- Yesterday, NSCEB Vice Chair Michelle Rozo kicked off the Commission's Biotech Across America roadshow in North Carolina where she met with multiple members from across North Carolina's biotechnology ecosystem. This summer, the NSCEB is hitting the road to highlight Biotechnology Across America, including the companies, academic institutions, industry alliances, workforce development programs, and policy initiatives that are driving the future for this rapidly growing industry. Commissioners intend to continue learning about the work being done across this vibrant ecosystem while engaging on the key findings and recommendations from the Commission's recent report to Congress. To follow the NSCEB's roadshow progress, visit: As events are scheduled, information will be updated. "The Commission's job is far from finished," said Dr. Michelle Rozo, Vice Chair of the NSCEB. "We are taking our report on the road and continuing the conversation with the people across America doing biotech work everyday. Together we can strengthen this vital ecosystem and advance our national and economic security." For the first stop in North Carolina, Vice Chair Rozo started in Raleigh where she discussed the state of the NC biotechnology industry with leaders from the North Carolina Biotechnology Center (NCBiotech) before meeting with Co-Chairs of the NC General Assembly's Life Sciences Caucus. She also joined leaders from industry and academia for a roundtable discussion on the ways North Carolina's leadership in biopharma manufacturing and workforce development is powering national progress across the biotech industry. Vice Chair Rozo and NSCEB staff then traveled to Franklinton, NC, to tour the Novonesis enzyme manufacturing facility, discuss recent agricultural biotechnology innovations that can serve as a cornerstone for national security, economic independence, and agricultural resilience. The group then closed the day by meeting with members of the North Carolina agricultural and industrial biotechnology community at a showcase of local biotech innovations. "For more than 40 years, NCBiotech and the state of North Carolina have been strategically investing in biotechnology and the life sciences," said Doug Edgeton, president and CEO of NCBiotech. "Given this critical moment for advancing U.S. leadership in biotechnology for national security and economic resilience, North Carolina is well positioned to execute on the Commission's recommendations, particularly around biomanufacturing, training, and domestic onshoring of critical supply chains for healing, feeding, and fueling the world." "The proactive measures proposed by the National Security Commission underscore a pivotal moment, not just a vision for a bio-based future, but the recognition that biotechnology and biosolutions are already shaping our world today," said Tue Micheelsen, President of Novonesis North America. "The tools to solve complex challenges and improve lives exist now, we simply need to amplify and extend them to reach everyone. At Novonesis, we are committed to accelerating this momentum, working to ensure these powerful innovations benefit communities everywhere. We invite all stakeholders, from policymakers to local leaders, to join us in expanding access to biology-driven solutions. Together, we can build a more sustainable, secure, and prosperous world." "The life sciences industry in North Carolina has been built on a strong foundation of support from our state legislature, municipalities and colleges and universities," said NCLifeSci President Laura Gunter. "The state's focus and foresight has built North Carolina into one of the nation's leading hubs for agricultural technology, defense, biotechnology and pharmaceuticals." Additional North Carolina participants included:Co-Chairs of NC Life Sciences Caucus (Rep. Donna White, Rep. Robert Reaves, Sen. Jay Chaudhuri, Sen. Benton Sawrey), North Carolina Life Sciences Organization, NC Biotechnology Center, Office of U.S. Senator Budd, Office of U.S. Senator Tillis, Office of U.S. Representative Rouzer, FUJIFILM Biotechnologies, North Carolina State University (BTEC, Plant Sciences Initiative, Bezos Center for Sustainable Protein, and Department of Food, Bioprocessing, and Nutrition Sciences), Ferment, Sable Fermentation, Elo Life Systems, Franklin County Economic Development, North Carolina Chamber of Commerce and Chamber Foundation, McGuireWoods, American Alliance for Biomanufacturing, BioMason, BIOME Consortia, TerraSafe, DMC Biotechnologies, Franklin County Schools, Innatrix, Keel Labs, Kiwanis Foundation of Franklin County, Iluma, North Carolina Farm Bureau, Novo Nordisk, Novonesis, Pairwise, PRTI Inc., SAS, Tar River Trading Post, United Way, Vance Granville Community College, Verb Biotics About NSCEB: The National Security Commission on Emerging Biotechnology is a time-limited, high-impact legislative branch advisory entity whose purpose is to advance and secure biotechnology, biomanufacturing, and associated technologies for U.S. national security and to prepare the United States for the bioindustrial revolution. The Commission published a comprehensive report in April 2025, including recommendations for action by Congress and the federal government. The bipartisan Commission is composed of Congressionally-appointed Commissioners with members from both the Senate and the House of Representatives as well as experts from industry, academia, and government. For more information about the Commission and to view the report, visit About Novonesis: Novonesis is a global company leading the era of biosolutions. By leveraging the power of microbiology with science, we transform the way the world produces, consumes, and lives. In more than 30 industries, our biosolutions are already creating value for millions of consumers and benefitting the planet. Our 10,000 people worldwide work closely with our partners and customers to transform business with biology. Learn more on About NCBiotech: Since 1984, the North Carolina Biotechnology Center has led life sciences technology-based economic development for the state by supporting the progression of ideas from the research lab to the marketplace. A private, non-profit state-funded corporation, NCBiotech invests in technology development through grants, in company development through loans, and in economic development through partnership development grants. Our transformational programs and activities develop strengths that yield high-paying life sciences jobs statewide. NCBiotech is headquartered in Research Triangle Park, with regional offices in Asheville, Charlotte, Greenville, Wilmington and Winston-Salem. To learn more, visit About NCLifeSci: NCLifeSci, the North Carolina Life Sciences Organization, is the trade association for North Carolina's life sciences industry. Founded in 1994, the organization advances the North Carolina life sciences industry and ecosystem, enabling its members to innovate and collaborate for success in a global marketplace. Contact: press@ View original content to download multimedia: SOURCE National Security Commission on Emerging Biotechnology
Yahoo
21 hours ago
- Yahoo
NSCEB Announces Biotech Across America Roadshow, Makes First Stop in North Carolina
NSCEB is launching a 3-month tour of the booming U.S. biotechnology ecosystem RALEIGH, N.C., June 6, 2025 /PRNewswire/ -- Yesterday, NSCEB Vice Chair Michelle Rozo kicked off the Commission's Biotech Across America roadshow in North Carolina where she met with multiple members from across North Carolina's biotechnology ecosystem. This summer, the NSCEB is hitting the road to highlight Biotechnology Across America, including the companies, academic institutions, industry alliances, workforce development programs, and policy initiatives that are driving the future for this rapidly growing industry. Commissioners intend to continue learning about the work being done across this vibrant ecosystem while engaging on the key findings and recommendations from the Commission's recent report to Congress. To follow the NSCEB's roadshow progress, visit: As events are scheduled, information will be updated. "The Commission's job is far from finished," said Dr. Michelle Rozo, Vice Chair of the NSCEB. "We are taking our report on the road and continuing the conversation with the people across America doing biotech work everyday. Together we can strengthen this vital ecosystem and advance our national and economic security." For the first stop in North Carolina, Vice Chair Rozo started in Raleigh where she discussed the state of the NC biotechnology industry with leaders from the North Carolina Biotechnology Center (NCBiotech) before meeting with Co-Chairs of the NC General Assembly's Life Sciences Caucus. She also joined leaders from industry and academia for a roundtable discussion on the ways North Carolina's leadership in biopharma manufacturing and workforce development is powering national progress across the biotech industry. Vice Chair Rozo and NSCEB staff then traveled to Franklinton, NC, to tour the Novonesis enzyme manufacturing facility, discuss recent agricultural biotechnology innovations that can serve as a cornerstone for national security, economic independence, and agricultural resilience. The group then closed the day by meeting with members of the North Carolina agricultural and industrial biotechnology community at a showcase of local biotech innovations. "For more than 40 years, NCBiotech and the state of North Carolina have been strategically investing in biotechnology and the life sciences," said Doug Edgeton, president and CEO of NCBiotech. "Given this critical moment for advancing U.S. leadership in biotechnology for national security and economic resilience, North Carolina is well positioned to execute on the Commission's recommendations, particularly around biomanufacturing, training, and domestic onshoring of critical supply chains for healing, feeding, and fueling the world." "The proactive measures proposed by the National Security Commission underscore a pivotal moment, not just a vision for a bio-based future, but the recognition that biotechnology and biosolutions are already shaping our world today," said Tue Micheelsen, President of Novonesis North America. "The tools to solve complex challenges and improve lives exist now, we simply need to amplify and extend them to reach everyone. At Novonesis, we are committed to accelerating this momentum, working to ensure these powerful innovations benefit communities everywhere. We invite all stakeholders, from policymakers to local leaders, to join us in expanding access to biology-driven solutions. Together, we can build a more sustainable, secure, and prosperous world." "The life sciences industry in North Carolina has been built on a strong foundation of support from our state legislature, municipalities and colleges and universities," said NCLifeSci President Laura Gunter. "The state's focus and foresight has built North Carolina into one of the nation's leading hubs for agricultural technology, defense, biotechnology and pharmaceuticals." Additional North Carolina participants included:Co-Chairs of NC Life Sciences Caucus (Rep. Donna White, Rep. Robert Reaves, Sen. Jay Chaudhuri, Sen. Benton Sawrey), North Carolina Life Sciences Organization, NC Biotechnology Center, Office of U.S. Senator Budd, Office of U.S. Senator Tillis, Office of U.S. Representative Rouzer, FUJIFILM Biotechnologies, North Carolina State University (BTEC, Plant Sciences Initiative, Bezos Center for Sustainable Protein, and Department of Food, Bioprocessing, and Nutrition Sciences), Ferment, Sable Fermentation, Elo Life Systems, Franklin County Economic Development, North Carolina Chamber of Commerce and Chamber Foundation, McGuireWoods, American Alliance for Biomanufacturing, BioMason, BIOME Consortia, TerraSafe, DMC Biotechnologies, Franklin County Schools, Innatrix, Keel Labs, Kiwanis Foundation of Franklin County, Iluma, North Carolina Farm Bureau, Novo Nordisk, Novonesis, Pairwise, PRTI Inc., SAS, Tar River Trading Post, United Way, Vance Granville Community College, Verb Biotics About NSCEB: The National Security Commission on Emerging Biotechnology is a time-limited, high-impact legislative branch advisory entity whose purpose is to advance and secure biotechnology, biomanufacturing, and associated technologies for U.S. national security and to prepare the United States for the bioindustrial revolution. The Commission published a comprehensive report in April 2025, including recommendations for action by Congress and the federal government. The bipartisan Commission is composed of Congressionally-appointed Commissioners with members from both the Senate and the House of Representatives as well as experts from industry, academia, and government. For more information about the Commission and to view the report, visit About Novonesis: Novonesis is a global company leading the era of biosolutions. By leveraging the power of microbiology with science, we transform the way the world produces, consumes, and lives. In more than 30 industries, our biosolutions are already creating value for millions of consumers and benefitting the planet. Our 10,000 people worldwide work closely with our partners and customers to transform business with biology. Learn more on About NCBiotech: Since 1984, the North Carolina Biotechnology Center has led life sciences technology-based economic development for the state by supporting the progression of ideas from the research lab to the marketplace. A private, non-profit state-funded corporation, NCBiotech invests in technology development through grants, in company development through loans, and in economic development through partnership development grants. Our transformational programs and activities develop strengths that yield high-paying life sciences jobs statewide. NCBiotech is headquartered in Research Triangle Park, with regional offices in Asheville, Charlotte, Greenville, Wilmington and Winston-Salem. To learn more, visit About NCLifeSci: NCLifeSci, the North Carolina Life Sciences Organization, is the trade association for North Carolina's life sciences industry. Founded in 1994, the organization advances the North Carolina life sciences industry and ecosystem, enabling its members to innovate and collaborate for success in a global marketplace. Contact: press@ View original content to download multimedia: SOURCE National Security Commission on Emerging Biotechnology